This inventor holds 1 USPTO granted patent. Top assignee: Schering Corporation. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: The Innovations of Jay Raman
Introduction
Jay Raman is an accomplished inventor based in Robbinsville, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the purification of human interleukin-4. His work has implications for various medical applications, showcasing his expertise and dedication to innovation.
Latest Patents
Jay Raman holds a patent for the "Purification of human interleukin-4 from a CHO-cell line culture medium." This patent describes a method for purifying active recombinant human IL-4 from a crude cell culture medium of CHO-cell lines. The process involves two sequential cation exchange chromatographies at pH 7.2 and 0.12M sodium chloride, followed by selective chromatography on a cobalt-chelating agarose column at pH 7.2 in a buffer with a high concentration of sodium chloride, approximately 0.5M. The solution is further treated by concentration (diafiltration) up to 20 mg/mL and size exclusion gel chromatography using a citrate buffer at pH 4.5. This innovative approach enhances the efficiency of IL-4 purification, which is crucial for therapeutic applications.
Career Highlights
Jay Raman is currently employed at Schering Corporation, where he continues to advance his research and development efforts. His work at Schering Corporation has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.
Collaborations
Some of Jay's notable coworkers include David Naveh and John C Tang. Their collaborative efforts have likely contributed to the success of various projects within the company.
Conclusion
Jay Raman's innovative work in the purification of human interleukin-4 exemplifies his commitment to advancing biotechnology. His contributions not only reflect his expertise but also have the potential to impact medical treatments significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
